Ledger.Open graph →
SEC Form D · filed December 21, 2015

Advantagene, Inc

Offering
$2.5M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
AUBURNDALE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Laura Aguilar · Auburndale, MAExecUdi C. Merav · Auburndale, MADirectorFred C. Mermelstein · Auburndale, MADirectorStephen C. Rocamboli · Auburndale, MAExecGlenn C. Mattes · Auburndale, MADirectorEstuardo Aguilar-Cordova · Auburndale, MAExec · DirectorMitchell C. Finer · Auburndale, MADirectorAlan C. Smith · Auburndale, MADirectorMaria Milagros A. Paredes · VANCOUVER, British Columbia, CanadaDirectorArlo Hoffman · Ellington, CTDirectorCyrus S. Driver · VANCOUVER, British Columbia, CanadaDirectorSeth Bahler · Tolland, CTExecRick Metzger · Morris, MNDirectorKenneth Luginbuhl · Ellington, CTExec · DirectorMatthew A. Blanchard · San Diego, CAExec · DirectorRobert S. Wasylyshyn · VANCOUVER, British Columbia, CanadaExec · DirectorRobert E. Weisskoff · Berkeley, CADirectorAndrew Ervin · Boston, MAExec · DirectorAlberto S. Montoya · VANCOUVER, British Columbia, CanadaDirectorRachel E. Haurwitz · Berkeley, CADirectorMats Lederhausen · Boston, MADirectorMarion A. Mcgrath · VANCOUVER, British Columbia, CanadaExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗